Literature DB >> 11976271

Dissociation of the PAF-receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium.

H C Steel1, R Anderson.   

Abstract

The magnitude and duration of the abruptly occurring increases in cytosolic Ca2+ in human neutrophils following activation with PAF (20 and 200 nM) and FMLP (1 microM), have been compared and related to alterations in NADPH oxidase activity, membrane potential and intracellular cyclic AMP. Cytosolic Ca2+ and membrane potential were measured by spectrofluorimetry, transmembrane fluxes of Ca2+ by radiometric procedures, and NADPH oxidase activity and cyclic AMP by chemiluminescence and radioimmunoassay respectively. Activation of neutrophils with both PAF (200 nM) and FMLP (1 microM) was accompanied by an abrupt increase in cytosolic Ca2+, which was of similar magnitude for each activator (393+/-9 and 378+/-17 nM respectively). Unlike FMLP-activated cells in which Ca2+ was rapidly removed from the cytosol, peak levels of cytosolic Ca2+ were sustained for longer (0.14+/-0.02 vs 1.16+/-0.04 min, P<or=0.0001) and declined at a slower rate in PAF-treated neutrophils. The prolonged elevation of cytosolic Ca2+ in PAF-treated cells was due to accelerated store-operated influx of extracellular cation and was attenuated by dibutyryl cyclic AMP (4 mM), the Ca2+-chelator, EGTA (5 mM), and SKF 96365 (10 microM). In contrast to FMLP, basal levels of superoxide production and cyclic AMP were unaltered in PAF-activated neutrophils, while only moderate membrane depolarization was detected. These observations demonstrate that mechanisms which restore Ca2+ homeostasis to FMLP-activated neutrophils, viz. activation of NADPH oxidase and adenylate cyclase, are not operative in PAF-treated cells, presenting the potential hazard of Ca2+ overload and hyperactivity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11976271      PMCID: PMC1762113          DOI: 10.1038/sj.bjp.0704685

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Inhibition of leukotriene formation and IL-8 release by the paf-receptor antagonist SM-12502.

Authors:  R A Hilger; M Köller; W König
Journal:  Inflammation       Date:  1996-02       Impact factor: 4.092

Review 2.  Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2 inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers.

Authors:  P V Peplow
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1999-08       Impact factor: 4.006

3.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

4.  SK&F 96365, a novel inhibitor of receptor-mediated calcium entry.

Authors:  J E Merritt; W P Armstrong; C D Benham; T J Hallam; R Jacob; A Jaxa-Chamiec; B K Leigh; S A McCarthy; K E Moores; T J Rink
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

5.  Chemotactic peptide induces cAMP elevation in human neutrophils by amplification of the adenylate cyclase response to endogenously produced adenosine.

Authors:  M A Iannone; G Wolberg; T P Zimmerman
Journal:  J Biol Chem       Date:  1989-12-05       Impact factor: 5.157

6.  U-73122, a phospholipase C antagonist, inhibits effects of endothelin-1 and parathyroid hormone on signal transduction in UMR-106 osteoblastic cells.

Authors:  A Tatrai; S K Lee; P H Stern
Journal:  Biochim Biophys Acta       Date:  1994-12-30

7.  Ca2+ homeostasis in permeabilized human neutrophils. Characterization of Ca2+-sequestering pools and the action of inositol 1,4,5-triphosphate.

Authors:  M Prentki; C B Wollheim; P D Lew
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

8.  Stimulation of dense tubular Ca2+ uptake in human platelets by cAMP.

Authors:  J Tao; J S Johansson; D H Haynes
Journal:  Biochim Biophys Acta       Date:  1992-03-23

9.  Platelet-activating factor induces NF-kappa B activation through a G protein-coupled pathway.

Authors:  V V Kravchenko; Z Pan; J Han; J M Herbert; R J Ulevitch; R D Ye
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

10.  Plasma membrane potential modulates chemotactic peptide-stimulated cytosolic free Ca2+ changes in human neutrophils.

Authors:  F Di Virgilio; P D Lew; T Andersson; T Pozzan
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

View more
  11 in total

Review 1.  Taming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control.

Authors:  G Tintinger; H C Steel; R Anderson
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

2.  Itraconazole antagonizes store-operated influx of calcium into chemoattractant-activated human neutrophils.

Authors:  H C Steel; R Anderson
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

3.  Protein kinase C promotes restoration of calcium homeostasis to platelet activating factor-stimulated human neutrophils by inhibition of phospholipase C.

Authors:  Gregory R Tintinger; Annette J Theron; Helen C Steel; Riana Cockeran; Lynette Pretorius; Ronald Anderson
Journal:  J Inflamm (Lond)       Date:  2009-10-30       Impact factor: 4.981

4.  Inhibitors of TRP channels reveal stimulus-dependent differential activation of Ca2+ influx pathways in human neutrophil granulocytes.

Authors:  Elena Pantaler; Andreas Lückhoff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-06       Impact factor: 3.000

5.  Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B4.

Authors:  H C Steel; G R Tintinger; A J Theron; R Anderson
Journal:  Clin Exp Immunol       Date:  2007-08-07       Impact factor: 4.330

6.  Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism.

Authors:  Ronald Anderson; Annette J Theron; Cornelia M Gravett; Helen C Steel; Gregory R Tintinger; Charles Feldman
Journal:  Br J Pharmacol       Date:  2008-12-06       Impact factor: 8.739

7.  Pharmacological control of neutrophil-mediated inflammation: strategies targeting calcium handling by activated polymorphonuclear leukocytes.

Authors:  Gregory R Tintinger; Helen C Steel; Annette J Theron; Ronald Anderson
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

Review 8.  Regulation of superoxide production in neutrophils: role of calcium influx.

Authors:  Sabrina Bréchard; Eric J Tschirhart
Journal:  J Leukoc Biol       Date:  2008-06-10       Impact factor: 4.962

9.  The beta-2-adrenoreceptor agonists, formoterol and indacaterol, but not salbutamol, effectively suppress the reactivity of human neutrophils in vitro.

Authors:  Ronald Anderson; Annette J Theron; Helen C Steel; Chrisna Durandt; Gregory R Tintinger; Charles Feldman
Journal:  Mediators Inflamm       Date:  2014-03-06       Impact factor: 4.711

10.  fMLP-Induced IL-8 Release Is Dependent on NADPH Oxidase in Human Neutrophils.

Authors:  María A Hidalgo; María D Carretta; Stefanie E Teuber; Cristian Zárate; Leonardo Cárcamo; Ilona I Concha; Rafael A Burgos
Journal:  J Immunol Res       Date:  2015-11-08       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.